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Abstract 
Background: TNF-α, an adipokine involved in systemic inflammation and a member of a group of cytokines that 
stimulate the acute phase reaction, has been related to the pathogenesis of both periodontitis and obesity. The objec-
tive of this study was to assess the serum levels of adiponectin, leptin and TNF-α of periodontally healthy normal 
weight (NW) patients, NW patients with chronic periodontitis (CP), periodontally healthy obese patients and obese 
patients with CP.
Material and Methods: Ninety-three patients were enrolled in this cross-sectional study: 30 periodontally healthy 
NW patients; 18 NW patients with CP; 21 periodontally healthy obese patients; and 24 obese patients with CP. 
Analyses included clinical and anthropometric outcomes, as well as the assessment of serum levels of adiponectin, 
leptin and  TNF-α by enzyme linked immunosorbent assay (ELISA) or fully automated chemiluminescence immu-
noassay. One-Way ANOVA, Kruskal-Wallis One-Way on Ranks, Dunn’s Test and multivariable logistic regression 
(MLR) analyses were conducted to estimate the degree of association between periodontitis and obesity.
Results: Obese patients with CP showed significant more bleeding sites than the other three groups (p<0.05). Mo-
reover, patients from the NWCP and OPH showed similar BOP percentages, as well as OPH group showed more 
bleeding sites than the NWPH group (p<0.05). The OPH group showed similar levels of adiponectin and leptin than 
the OCP group, but significantly higher than the NWPH and NWCP groups(p<0.05). MLR analyses showed that 
obesity was positively associated with the percentage of sites with bleeding on probing, with an odds ratio of 0.93 
(95% confidence interval: -0.88, - 0.98; p=0.012).
Conclusions: The serum levels of adiponectin, leptin and TNF-α were not influenced by CP. Obese patients showed 
almost 10% more sites with BoP. In chronic periodontitis patients, obese subjects presented significant more BOP 
sites than normal weight subjects.
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Introduction
It is well-established that the development and progres-
sion of chronic periodontitis (CP) is directly linked to 
dental biofilm accumulation on dental surfaces (1-3). If 
left undisturbed, dental plaque biofilms stimulate the in-
flammation of the periodontal tissue, as well as an activa-
tion of a ceaseless host response that may trigger perio-
dontal destruction (1). Despite being focal and confined 
to the oral cavity, CP generates an inflammatory burden 
that may interact with other body environments, syste-
mic diseases and conditions, such as adverse pregnancy 
outcomes (4), atherosclerotic cardiovascular disease (5), 
chronic kidney disease (6) and diabetes mellitus (7,8).
The progression of CP may also be affected by other 
conditions such as smoking (9-11) and diabetes mellitus 
(7). It has been suggested, that this complex and conco-
mitant interplay of different biologic processes seems to 
associate periodontitis to obesity (12). Obesity, defined 
by the World Health Organization (WHO) (13) was ab-
normal or excessive fat accumulation that may impair 
health’, is evaluated by the body mass index (BMI), 
i.e.  a person’s weight in kilograms divided by the squa-
re of his height in meters (kg/m2). The WHO estimates 
that more than 1.4 billion adults > 20 years of age are 
overweight, and out of this number, more than of 500 
million are obese. Greater than 2.8 million people die 
every year as a consequence of being overweight and/or 
obesity. These conditions are also associated to 44% of 
the diabetes mellitus burden and 23% of the population 
suffering from ischemic heart disease (13). 
Efforts have been made to comprehend the endocrine 
features of white adipose tissue and its role in the pro-
duction of two important adipocytokines: adinopectin 
and leptin (14). The first is an anti-inflammatory protein 
that modulates glucose metabolism, fatty acids, and im-
mune response, whereas the second is a pro-inflamma-
tory peptide hormone that regulates food intake, energy 
balance, fat storage and the secretion of other cytokines 
(14,15). Reduced serum concentrations of adiponectin 
are associated with obesity, insulin resistance and type 
2 diabetes mellitus (14,16). Conversely, obese subject 
may present elevated serum leptin levels (17).
Systematic review outcomes revealed that obese subjects 
may present more attachment loss than non-obese sub-
jects, and that patients with periodontitis reported grea-
ter body mass indexes (BMI) than periodontally healthy 
subjects (18,19). These studies also suggested that chro-
nic inflammatory processes occurring in the periodon-
tium of patients with periodontal disease may lead to 
systemic inflammation and secretion of locally produced 
pro-inflammatory cytokines/mediators (18,19). TNF-α, 
an adipokine involved in systemic inflammation and a 
member of a group of cytokines that stimulate the acute 
phase reaction, has been related to the pathogenesis of 
both periodontitis (20) and obesity (21). 
Previous studies have reported increased serum levels of 
leptin in patients with periodontitis (17,22). More recent 
investigations (23) reported that periodontitis was asso-
ciated with reduced levels of serum adiponectin, and that 
obesity and periodontitis may regulate the serum levels 
of leptin in favor of proinflammation. In addition, these 
authors found amongst subjects with periodontitis,obese 
or normal weighing, a significant increase in TNF-α le-
vels in sites with probing depths greater than 5mm.
Thus, the objective of this study was to assess the serum 
levels of adiponectin, leptin and TNF-α of periodontally 
healthy (PH) normal weight (NW) subjects, NW sub-
jects with chronic periodontitis (CP), PH obese subjects 
and obese subjects with CP.
Material and Methods 
-Ethical Consideration and Study Design
This cross-sectional study was approved by the Ethics 
on Research Committee of the Faculty of Dentistry at 
the Científica del Sur University, and was conducted in 
accordance with the Helsinki Declaration of 1975 as re-
vised in the year 2000. The subjects participating in the 
study were volunteers who received detailed informa-
tion regarding the proposed research and provided sig-
ned informed consent. In addition, the study design was 
prepared according to The Strengthening the Reporting 
of Observational Studies in Epidemiology (STROBE) 
statement (24). 
-Study Population and Inclusion Criteria
Ninety three systemically healthy, non-smoking sub-
jects, 25 male and 68 female, 30 to 60 years old (mean 
age: 42.6 years), participated in the study. These subjects 
were selected from an initial sample of 600 patients who 
were referred for dental treatment at the dental clinic of 
Científica del Sur University and at two private practi-
ces between July 2012 and January 2013. The patients 
were enrolled in the study when they met the following 
inclusion criteria: 1) age > 30 years; 2) at least 15 teeth, 
excluding third molars; 3) non-smoking status; and 4) 
a normal weight or obese type I or II status (13). All 
consecutive patients who met these inclusion criteria 
were invited to participate in the study. Patients with 
a diagnosis of gingivitis or aggressive periodontitis, a 
known systemic disease such asacquired immunodefi-
ciency syndrome [AIDS] or diabetes mellitus, pregnant/
lactating, currently undergoing orthodontic treatment or 
submitted to periodontal therapy within the previous 12 
months, or having undergone antimicrobial, anti-inflam-
matory and/or immunosuppressive therapies during the 
previous 6 months were excluded from the study.
-BMI Assessment 
BMI was calculated based on each subject’s weight in 
kilograms divided by the square of his height in meters 
(kg/m2). Weight and height measurements were perfor-
med by the same trained examiners. Subjects were clas-
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sified as obese if they presented. Obesity was defined 
according to the WHO (2012) as type I (i.e. BMI greater 
than or equal to 30 kg/m2 but less than35 kg/m2) or type 
II (i.e. BMI greater than or equal to 35 kg/m2 but less 
than 40 kg/m2). NW was defined as BMI ranging from 
20 to 24.9 kg/m2.
-Clinical examination 
Full medical and dental histories were obtained. Data 
included full mouth probing depth (PD) measured at six 
sites around the teeth, clinical attachment level (CAL) 
and presence or absence of bleeding on probing using a 
UNC-15 periodontal probe recorded by two trained and 
calibrated periodontists. (kappa intra-class correlation 
coefficient > 0.82 for PD and CAL). Patients without a 
history of periodontitis, no sites with PD and CAL > 3 
mm concomitantly were included in the periodontally 
healthy groups. Those exhibiting bleeding on probing in 
at least four teeth with a PD >4 mm were entered to the 
chronic periodontitis group. Chronic periodontitis (CP) 
was defined according to the criteria established by the 
World Workshop and the American Academy of Perio-
dontology (25). 
-Sample Size Calculation and Experimental Groups
Sample size calculation was performed based on the fin-
dings of a previous study (23). The primary outcome was 
considered TNF alpha levels. Considering an expected 
standard deviation of 2.8 pg/ml, the required number of 
subjects to detect a relevant mean difference of 2.5 pg/ml 
between any two of the four groups (alpha = 5%, power = 
80%) was estimated at 17 patients for each group.
Following the assessment of clinical and BMI outco-
mes, subjects were divided into four groups: 1) NWPH 
(n=30): NW subjects without CP; 2) NWCP (n=18): NW 
subjects with CP; 3) OPH (n=21): Obese subjects wi-
thout CP; and 4) OCP (n=24): Obese subjects with CP.
-Serum sampling
Serum samples were obtained as described in a previous 
investigation (23). Peripheral blood samples were co-
llected in the morning and one week after clinical exa-
mination into a proper tube. Subsequently, the serum 
was separated from blood by centrifugation (10 min at 
1,300 rpm) and stored at -80°C. Serum levels of adipo-
nectin and leptin were analyzed by enzyme linked im-
munosorbent assay (ELISA), as well as TNF-α by fully 
automated chemiluminescence immunoassay. The ran-
ges of detection for adiponectin, leptin and TNF-α were 
2.0 to 20.0 ug/ml (male) and 4.0 to 22.0 ug/ml (female), 
1.0 to 10.0 ng/ml (male) and 4.0 to 25.0 ng/ml (fema-
le), and 2.0 to 7.8 pg/ml, respectively. In addition, serum 
sampling was performed at a biomedical laboratory con-
tracted for such specific purpose, and sample tubes were 
identified only by the name of the subject.
-Statistical Analysis
Descriptive statistics were used to synthesize collected 
data. The modified-Levene test was applied to test for 
equality of variance. Differences between the groups for 
Age, BoP, CAL, adiponectin, leptin, and TNF-α were 
analysed using One-Way Analysis of Variance (ANO-
VA) or Kruskal-Wallis One-Way ANOVA on Ranks 
(when the variances were considered not equal by Modi-
fied Levene Equal-Variance test). Kruskal-Wallis Multi-
ple-Comparison Z-Value Test (Dunn’s Test) was applied 
when significant differences were found. 
Two sets of multivariable logistic regression (MLR) 
models were performed to investigate the association 
between periodontitis and obesity using each patient as 
the unit of analysis – a total of six MLR analyses were 
performed, three testing the influence of CP on obesity 
and three testing the influence of obesity on CP. Odds 
ratio (OR) with a 95% confidence interval were calcu-
lated. The first MLR analysis explored the relationship 
between age, BOP, gender and CP and obesity (the de-
pendent variable was the diagnosis of obesity). The se-
cond and third analyses assessed the same independent 
variables versus the specific diagnosis of obesity. Adipo-
cytokines outcomes’ were not included in these analyses 
since obese subjects present significant higher serum le-
vels than normal weighted subjects (13).
The fourth MLR model evaluated the influence of age, 
gender, obesity and serum levels of adipocytokines with 
CP (the dependent variable was the diagnosis of CP). 
For the fifth and sixth MLR analyses, the independent 
variables were the serum levels of adipocytokines; and 
the dependent variables were the patients with CP + obe-
sity (overall analysis) and  patients with CP + obesity 
presenting sites with PD>  5mm, respectively. For these 
models, BOP and CAL outcomes were not included in 
these analyses since subjects with CP present significant 
BOP and attachment loss than periodontally healthy 
subjects. The analyses were performed using the NCSS 
2007 software package (Number Cruncher Statistical 
System, NCSS, Kaysville, UT, USA). Differences at p < 
0.05 were considered statistically significant.
Results
Table 1 shows the demographic and periodontal condi-
tions of the four examined groups. There were no signifi-
cant differences between groups regarding age (p>0.05). 
For CAL, Kruskal-Wallis Multiple-Comparison Z-Value 
Test confirmed the similarity between NWPH and OPH 
groups, as well as between NWCP and OCP groups. 
Also, differences between periodontally healthy and CP 
groups were confirmed (P<0.05). Concerning BOP, obe-
se subjects with CP showed significant more bleeding 
sites than the other three groups (p<0.05). Moreover, 
subjects from the NWCP and OPH showed similar BOP 
percentages, as well as OPH group showed more blee-
ding sites than the NWPH group (p<0.05). 
With respect to individual adipocytokines outcomes (Ta-
ble 2), the OPH group showed similar levels of adipo-
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Table 1. Demographic and periodontal characteristics (mean + standard deviations) of the study population.
Parameters NWPH NWCP OPH OCP
Age (years)# 42.5 + 7.5 41.4 + 6.5 42.9 + 7.8 43.5 + 7.3
Gender (M/F) 5/24 9/10 4/17 6/18
BoP (%)* 22.0 + 3.6a 39 + 16.4b 26.9 + 8.1b 47.2 + 10.8c
CAL (mm)* 2.3 + 0.3a 3.1 + 0.5b 2.4 + 0.3a 3.2 + 0.5b
BoP – bleeding on probing; CAL – clinical attachment level; NWPH - normal weight/periodontally 
healthy; NWCP – normal weight/chronic periodontitis; OPH – obese/periodontally healthy; OCP – obese/
chronic periodontitis (#One-Way ANOVA; *Kruskal-Wallis One-Way ANOVA on Ranks/Kruskal-Wal-
lis Multiple-Comparison Z-Value Test [Dunn’s Test]; p<0.05).
Parameters NWPH NWCP OPH OCP
Adiponectin (ug/ml)* 7.2 + 5.8a 10.5 + 9.7ac 17.5 + 11.0b 13.6 + 12.6bc
Leptin (pg/ml)* 11.9 + 5.2ac 9.9 + 8.9a 16.4 + 5.4b 13.5 + 5.2bc
TNF-α (pg/ml)* 3.5 + 1.3 4.9 + 3.1 5.1 + 3.9 4.6 + 2.5
Table 2. Serum levels of adipocytokines (mean + standard deviations).
BoP – bleeding on probing; CAL – clinical attachment level; NWPH - normal weight/periodontally 
healthy; NWCP – normal weight/chronic periodontitis; OPH – obese/periodontally healthy; OCP – 
obese/chronic periodontitis; TNF – tumoral necrosis factor Different letters indicate differences between 
groups (*Kruskal-Wallis One-Way ANOVA on Ranks/Kruskal-Wallis Multiple-Comparison Z-Value 
Test [Dunn’s Test]; p<0.05).
nectin and leptin than the OCP one, but significant hig-
her than NWPH and NWCP (p<0.05). However, leptin 
levels were significant higher for the OCP group when 
compared to the NWCP group (p<0.05). For TNF-α le-
vel/]s, there were no statistically significant differences 
between groups (p>0.05).
The degree of association between obesity and CP was 
investigated by MLR analyses (Tables 3-6) based on 
different dependent variables (i.e. diagnosis of obesity, 
type of obesity [I or II], diagnosis of CP, diagnosis of 
obesity + CP, and diagnosis of obesity + CP and presen-
ce of site exhibiting PD > 5mm). The first and second 
MLR models found that obese subjects, with CP or not, 
present significantly more bleeding sites than normal 
weight individuals with odds ratio of 0.93 (95% confi-
dence interval (CI): -0.88, 0.98 , -0.01; Wald z –value 
= -2.65; p = 0.007) and 0.92 (95% confidence interval 
(CI): -0.87 , - 0.98; Wald z –value = -2.35; p = 0.018), 
respectively. For the third MLR analyses, a significant 
association between the type of obesity and the sus-
pected independent variables was not found (p>0.05). 
Regarding the MLR models assessing the influence of 
obesity on CP, none of them demonstrated statistically 
significant associations between the suspected indepen-
dent variables and the tested dependent ones (p>0.05).
Discussion
It may be difficult to accurately predict periodontitis 
progression if conditions known to influence the host 
response are also present. Previous studies have inves-
tigated the interaction effects with diabetes mellitus and 
smoking (10,19). Moreover, it has also been considered 
the potential impact of periodontal disease on systemic 
health, such as adequate glycaemic control, cardiovas-
cular and renal diseases (19,5-8). Regarding the influen-
ce of CP on the levels of adipocytokines, the potential 
association has been considered an important condition 
in periodontal research.  For instance, a recent systema-
tic review found that subjects with periodontal disease 
have a 30% greater chance of obesity, as well as higher 
BMI and CAL loss (18). On the other hand, the same 
authors did not find prospective observational studies, 
and thus they considered that it could not be possible 
to establish causal association (18). The present study 
failed to sustain these assumptions. Overall, obese sub-
jects with CP presented more bleeding sites than perio-
dontal healthy ones. Moreover, there was a statistically 
significant equivalency between normal weight subjects 
with CP and obese ones without CP. CAL was similar 
between healthy groups and between CP groups, but sta-
tistically higher when comparing healthy to CP groups 
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OR SE   Z P>|z| 95% CI
Chronic periodontitis (yes) 1.85 0.68
 
 0.90 0.368 0.48         7.08
Gender (male) 1.66 0.53  0.95 0.341 0.58         4.72
Age 0.97 0.03 -0.77 0.439 0.92         1.03
BoP 0.93 0.02   -2.65 0.007 0.88        0.98
Table 3. Multivariable logistic regression analysis estimating the interaction effects between periodontal status with 
a diagnosis of obesity (overall).
BoP – bleeding on probing;  CI: confidence interval; OR – odds ratio; SE – standard error; z – Wald z-value.
Obesity type I
OR SE   z P>|z| 95% CI
Chronic periodontitis (yes) 5.03 0.96   1.67 0.093 0.76       33.19
Gender (male) 0.76 0.60  -0.43 0.664 0.23         2.52
Age 0.98 0.03 -0.26 0.787 0.92         1.06
BoP 0.92 0.03   -2.35 0.018 0.87        0.98
Obesity type II
OR SE   z P>|z| 95% CI
Chronic periodontitis (yes) 0.61 0.66   -0.72 0.469 0.16         2.28
Gender (male) 2.35 0.59  1.43 0.151 0.73         7.61
Age 0.97 0.03 -0.64 0.519 0.91         1.04
BoP 0.98 0.02   -0.84 0.399 0.93         1.02
Table 4. Multivariable logistic regression analysis estimating the interaction effects between periodontal status with a 
diagnosis of obesity (type I or type II).
BoP – bleeding on probing;CI: confidence interval; OR – odds ratio; SE – standard error; z – Wald z-value.
OR SE    z P>|z| 95% CI
Age 1.00 0.03   0.24 0.804 0.94         1.07
Gender (male) 0.35 0.73    -1.41 0.158 0.08        1.49
Adiponectin 1.00 0.02     0.12 0.897 0.96         1.04
Leptin 1.01 0.05   0.22 0.819 0.91         1.12
TNF-α 0.92 0.08  -0.95 0.339 -0.23         0.08
Obesity (yes) 0.48 0.49    -1.47 0.140 0.78         1.08
Table 5. Multivariable logistic regression analysis estimating the interaction effects between age, gen-
der, adipocytokines levels and obesity with a diagnosis of chronic periodontitis.
BoP – bleeding on probing; CAL – clinical attachment level; CI: confidence interval; OR – odds ratio; 
SE – standard error; z – Wald z-value.
(p <0.0001). This finding suggests that obese individuals 
may be at an increased risk of more severe clinical perio-
dontal inflammation (as measured by BoP) even when a 
healthy periodontal status is present.
Furugen et al. compared the serum levels of different 
adipocytokines and periodontal status (26) reporting no 
significant differences in the serum levels of adiponectin 
and TNF-α between subjects with and without perio-
dontitis. Saito et al. did not find asignificant association 
between periodontitis and adiponectin in middle-aged. 
Japanese women (27) found significant lower levels of 
adiponectin in subjects with periodontitis, as well as 
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Obesity + CP
OR SE   z P>|z| 95% CI
Age 0.98 0.03
 
 -0.52 0.599 0.91         1.05
Gender (male) 0.60 0.78  -0.63 0.525 0.13         2.83
Adiponectin 0.98 0.02 -0.73 0.464 0.94         1.02
Leptin 0.96 0.05   -0.60 0.547 0.86         1.07
TNF-α 0.97 0.08   -0.26 0.790 0.82         1.15
Obesity +    CP    PD > 5 mm
OR SE   z P>|z| 95% CI
Age 1.02 0.05
 
 0.44 0.655 0.92         1.13
Gender (male) 0.34 1.14  -0.93 0.348 0.03         3.21
Adiponectin 0.96 0.03 -1.01 0.309 0.91         1.02
Leptin 0.98 0.08    -0.19 0.842 0.83         1.15
TNF-α 1.03 0.13     0.24 0.806 0.78         1.35
Table 6. Multivariable logistic regression analysis estimating the interaction effects between age, gender, 
adipocytokines levels and a diagnosis of obesity + chronic periodontitis.
BoP – bleeding on probing; CAL – clinical attachment level; CI: confidence interval; OR – odds ratio; SE – 
standard error; z – Wald z-value.
suggested that this anti-inflammatory marker could be 
used to periodontal assessment (28) did not find a positi-
ve relationship between the serum levels of adiponectin, 
leptin, resistin, interleukin-6 and TNF-α and CP. 
Regarding obesity, to the best of our knowledge, this is 
the second cross-sectional study designed to assess the 
relationship between serum levels of adipocytokines and 
CP in obese and normal weight subjects. Most of the 
present outcomes are in line with data from the study 
performed by Zimmerman et al. (23). On the other hand, 
several differences between each individual study`s 
outcomes deserve some attention: 1) In this study, all 
groups presented a similar mean age. Zimmmerman et 
al. (23) argued that the levels of adipocytokines could 
be linked to differences in mean age of their groups ins-
tead of being linked to CP, as well as that other factors 
such as ethnicity and gender, might be related to adipose 
tissue and adipocytokines` levels; 2) Conversely to  the 
previous publications, all the included patients presented 
similar ethnicity and food intake (Amerindian-Spanish) 
what may have assisted in recruiting subjects with simi-
lar body fat composition and distribution; 3) Inversely 
to Zimmerman et al. findings (23), the serum levels of 
adiponectin were similar between obese groups, but hig-
her for OPH when both NW groups were compared (p = 
0.0009). Moreover, NWCP and OCP groups reported si-
milar adiponectin levels  supporting the suggestion that 
periodontal inflammation seems to regulate the level of 
this anti-inflammatory adipcytokine as well  (23,29). It 
has been shown that adiponectin regulates inflammation 
by preventing the stimulation of pro-inflammatory cyto-
kines and allowing the discharge of anti-inflammatory 
mediators (15). However, previous data suggested that 
the serum levels of adipinectin seem to be lower in sub-
jects with periodontitis when compared to healthy sub-
jects (26,27); 4) Regarding leptin levels, the lowest lep-
tin levels were seen in normal weight subjects with CP 
instead of in normal weight subjects without CP, as well 
as MLR analysis associated obesity to CP (23). It has 
been shown that leptin leads to an important function 
in host defense mechanisms because of its role on pro-
inflammatory stimuli (30). In fact, both PH groups and 
CP groups presented similar levels (that is, they were 
not statistically different), but NWPH subjects showed 
similar outcomes to OCP individuals, and OPH subjects 
presented the highest levels (p = 0.007). These findings 
suggest that CP may decrease the serum levels of leptin; 
and 5) it has been suggested that the higher levels of 
TNF-α reported to OPH in comparison to NWPH could 
be partially associated to obesity even without the pre-
sence of a periodontal diagnosis. The present outcomes 
do not support this assumption as no significant diffe-
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rences between groups could be detected (neither the 
Kruskal-Wallis test nor the MLR models). Earlier data 
positively linked BMI to TNF-α serum levels (31), but 
methodological discrepancies, such as the criteria used 
to assess CP and obesity and the laboratorial tests applied 
to quantify the serum levels may reflect the differences 
between samples (23). 
In addition, in this cross-sectional study, only a ‘snaps-
hot’ of the potential link between CP and obesity could 
be analyzed. Also, the diagnosis of obesity was based on 
BMI alone as proposed by the World Health Organiza-
tion (2012); however, it has been argued that a diagnosis 
based on BMI and waist-hip ratio may provide a better 
characterization of this condition (23). Besides, gingival 
crevicular fluid was not collected from sites with PD > 
5 mm to test for differences between serum levels and 
locally produced inflammatory cytokines.  Due to the 
limited data available, further studies have to be per-
formed to assess the impact of CP on the serum levels 
of adipocytokines. Non-significant differences between 
groups may be associated to type-II statistical error.
Conclusions
In conclusion and within the limits of this study, it was not 
possible to establish a positive link between CP and obesity 
in terms of differences in the levels of adiponectin, leptin 
and TNF-α between obese and NW subjects with and wi-
thout periodontitis. However, obese subjects showed signi-
ficant more bleeding sites than NW ones. In addition, the 
serum levels of adipocytokines of periodontally healthy 
obese subjects were similar to normal weight with CP.
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